Market Analysts see AMGEN Inc. [AMGN] gaining to $335. Time to buy?

AMGEN Inc. [NASDAQ: AMGN] traded at a low on Wednesday, posting a -5.46 loss after which it closed the day’ session at $312.86.

The results of the trading session contributed to over 3913389 shares changing hands. Over the past one week, the price volatility of AMGEN Inc. stands at 2.28% while the volatility over the past one month is 2.00%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The market cap for AMGN stock reached $168.11 billion, with 537.33 million shares outstanding and 536.01 million shares in the current float. Compared to the average trading volume of 1.97M shares, AMGN reached a trading volume of 3913389 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about AMGEN Inc. [AMGN]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMGN shares is $325.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMGN stock is a recommendation set at 2.19. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for AMGEN Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on August 07, 2024. The new note on the price target was released on May 03, 2024, representing the official price target for AMGEN Inc. stock. Previously, the target price had yet another raise from $230 to $300, while Barclays kept a Equal Weight rating on AMGN stock.

The Average True Range (ATR) for AMGEN Inc. is set at 7.17, with the Price to Sales ratio for AMGN stock in the period of the last 12 months amounting to 5.47. The Price to Book ratio for the last quarter was 28.37, with the Price to Cash per share for the same quarter was set at 17.31. Price to Free Cash Flow for AMGN in the course of the last twelve months was 30.67 with Quick ratio for the last quarter at 0.89.

How has AMGN stock performed recently?

AMGEN Inc. [AMGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.03. With this latest performance, AMGN shares dropped by -4.26% in over the last four-week period, additionally plugging by 11.03% over the last 6 months – not to mention a rise of 17.24% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMGN stock in for the last two-week period is set at 33.52, with the RSI for the last a single of trading hit 25.52, and the three-weeks RSI is set at 38.94 for AMGEN Inc. [AMGN]. The present Moving Average for the last 50 days of trading for this stock 329.21, while it was recorded at 330.54 for the last single week of trading, and 302.58 for the last 200 days.

AMGEN Inc. [AMGN]: Deeper insight into the fundamentals

AMGEN Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.89 and a Current Ratio set at 1.26.

Earnings analysis for AMGEN Inc. [AMGN]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AMGEN Inc. go to 5.60%.

Insider trade positions for AMGEN Inc. [AMGN]

There are presently around $81.10%, or 81.31%% of AMGN stock, in the hands of institutional investors. The top three institutional holders of AMGN stocks are: VANGUARD GROUP INC with ownership of 51.87 million shares, which is approximately 9.6779%. BLACKROCK INC., holding 46.04 million shares of the stock with an approximate value of $$14.39 billion in AMGN stocks shares; and BLACKROCK INC., currently with $$9.05 billion in AMGN stock with ownership which is approximately 5.4051%.

Most Popular